Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab
NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021
Telemedicine in Neurology
Neurol 94:30-38,16, Hatcher-Martin, J.M.,et al, 2020
PET Imaging for Alzheimer Disease: Are Its Benefits Worth the Cost?
JAMA 309:1099-1100, Mitka, M., 2013
Disability, distress and unemployment in neurology outpatients with symptoms unexplained by organic disease
JNNP 82:810-813, 710, Carson, A.,et al, 2011
American Academy of Neurology Telehealth Position Statement
Neurol 97:334-339, Hatcher-Martin, J.M.,et al, 2021
Neuro R� score
Neurol 94:e1614-e1621, Peacock, S.H.,et al, 2020
Complications from "Stem Cell Tourism" in Neurology
Ann Neurol 88:661-668, Julian, K.,et al, 2020
Multiple Sclerosis
NEJM 378:169-180, Reich, D.S.,et al, 2018
Clinical and Biomarker Changes in Dominantly Inherited Alzheimers Disease
NEJM 367:795-804,864, Bateman, R.J.,et al, 2012
Should TIA Patients Be Hospitalized or Referred to a Same-Day Clinic?
Neurol 77-2082-2088, Joshi, J.K.,et al, 2011
Detection of Paroxysmal Atrial Fibrillation with Transtelephonic EKG in TIA or Stroke Patients
Neurol 74:1666-1670, 1662, e94, Gaillard,N., et al, 2010